Edwards Lifesciences Corporation (EW) Stock Analysis & Investment Frameworks
Edwards Lifesciences Corporation (EW) stock analysis on Invetso. Review Edwards Lifesciences Corporation’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Edwards Lifesciences Corporation Company Overview
- Exchange: New York Stock Exchange
- Sector: Healthcare
- Industry: Medical - Devices
- Country: US
Edwards Lifesciences Corporation Key Financial Metrics
- Market Cap: $51.93B
- Revenue: $6.07B
- P/E Ratio: 48.44
- ROE: 9.69%
- ROIC: 10.20%
- Dividend Yield: N/A
About Edwards Lifesciences Corporation
Edwards Lifesciences Corporation is a global medical technology firm specializing in sophisticated products and technologies for structural heart conditions, alongside critical care and surgical patient monitoring. With operations spanning the United States, Europe, Japan, and various international territories, the company offers a comprehensive suite of solutions. Their structural heart disease portfolio encompasses transcatheter heart valve replacement systems designed for minimally invasive procedures, as well as transcatheter repair and replacement options specifically targeting mitral and tricuspid valve pathologies, exemplified by their PASCAL and Cardioband systems. Additionally, they provide advanced surgical structural heart solutions, including the INSPIRIS aortic surgical valve, the KONECT RESILIA pre-assembled aortic tissue valved conduit for complex valve, root, and ascending aorta replacements, and the HARPOON Beating Heart Mitral Valve Repair System for patients suffering from degenerative mitral regurgitation. In the realm of critical care, Edwards supplies advanced hemodynamic monitoring systems that assess patients' cardiac function and fluid status in both surgical and intensive care environments. This offering also features the Acumen Hypotension Prediction Index software, which provides early alerts to clinicians regarding potential dangerously low blood pressure. The company distributes its products to healthcare providers through a combination of its proprietary sales force and independent distributor networks. Founded in 1958, Edwards Lifesciences Corporation maintains its headquarters in Irvine, California.
Edwards Lifesciences Corporation Investment Frameworks
Invetso analyzes Edwards Lifesciences Corporation (EW) across the following frameworks:
- Edwards Lifesciences Corporation 10Y Growth Potential
- Edwards Lifesciences Corporation Scenario Analysis
- Edwards Lifesciences Corporation Risks & Opportunities
- Edwards Lifesciences Corporation Economic Moat
- Edwards Lifesciences Corporation Business Model
- Edwards Lifesciences Corporation Management
- Edwards Lifesciences Corporation SWOT Analysis
- Edwards Lifesciences Corporation Porter's 5 Forces
- Edwards Lifesciences Corporation PESTLE Analysis
- Edwards Lifesciences Corporation ESG Analysis